FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Templeton Emerging Markets Income Fund [NYSE: TEI] today announced a monthly distribution from…
Año: 2023
Franklin Universal Trust (“FT” or the “Fund”) Announces Distribution
SAN MATEO, Calif.–(BUSINESS WIRE)–Franklin Universal Trust [NYSE: FT] today announced a monthly distribution from net investment…
BIOLINERX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioLineRx Ltd. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that…
G-III ALERT: Bragar Eagel & Squire, P.C. is Investigating G-III Apparel Group, Ltd. on Behalf of G-III Stockholders and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating…
The Shortcut Announces Its Inaugural CES 2023 Award Winners
Gaming and TV Announcements Rule Supreme With Bigger, Better and More Vibrant Offerings Than Ever Before…
Genexine to Present Final Phase 2 Clinical Data on Its Cervical Cancer Program Showing a 35.0% Overall Response Rate and Provide a Corporate Overview During JP Morgan Conference
SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the…
‘No Say Day’: the Last Day Youth Voices Are Represented in Parliaments Around the World
50% of the world’s population is under 30, compared to just 2.6% of parliamentarians globally*. If…
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2022 Results
2022 total revenue expected to meet or exceed top end of guided range of $132–137 million…
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2022 Global Net Product Revenues and Provides Additional Updates
– Achieved Full Year 2022 Preliminary Global Net Product Revenues of $894 Million for ONPATTRO®, AMVUTTRA®,…
Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) (Cybin or the Company), a biopharmaceutical company focused on…